|
Laxman Pai, Opalesque Asia: Forbion has unveiled its largest haul to date, as the European life-sciences-focused venture capital (VC) firm amassed more than 2 billion euros ($2.2 billion) across two funds.
The Naarden, The Netherlands-based firm exceeded its targets for its two newest funds, Forbion Growth Opportunities III and Forbion Ventures VII, by bringing in 1.2 billion euros ($1.3 billion) and 890 million euros ($980 million), respectively. The latest raises bring the firm's total assets under management to 5 billion euros ($5.4 billion).
"The fundraising enables an increase of both the number of investments and the average size of Forbion's participation in future portfolio company financings, reflecting the opportunities it sees for superior returns in development-stage life sciences companies," said the release.
It is anticipated that the Forbion Growth Opportunities Fund III and Forbion Ventures Fund VII will each invest in approximately 15 portfolio companies.
Sander Slootweg, Managing Partner and co-founder of Forbion said: "With greater levels of capital, we can extend more support to our portfolio companies as they grow and seek to maximize their potential. We continue to see great opportunities to deploy capital in Europe and North America, backing talented management teams that develop novel therapeutics with the potential to impact the future of medicine."
Robbert van de Griendt, General Partner, Investor Relations and Impact said: "The st...................... To view our full article Click here
|
RSS
